Literature DB >> 17541941

Co-inoculation of prostate cancer cells with U937 enhances tumor growth and angiogenesis in vivo.

Matthew Craig1, Chi Ying, Robert D Loberg.   

Abstract

Tumor-associated macrophages (TAMs) have been implicated in promoting tumor growth and development. Here we present evidence that demonstrates that co-inoculation of male athymic nude mice with PC-3 prostate cancer cells and U937 promonocytic cells enhances tumor growth and increases tumor angiogenesis. Male athymic nude mice were co-inoculated with PC-3 and U937 cells (control or IL-4 stimulated) and tumor growth was monitored over time. Immunohistochemical analysis of tumor specimens was performed for proliferation markers (e.g., Ki67) and the effects of IL-4 stimulation on U937 cells were analyzed for chemokine expression. The presence of U937 cells increased the rate of tumor growth in vivo and stimulated increased microvascular density within the tumor bed. Stimulation of U937 cells with IL-4 resulted in a significant increase in several pro-angiogenic and pro-tumor chemokines (e.g., CCL2). Co-inoculation increases prostate cancer growth via upregulation of chemokines that induce angiogenesis within the tumor. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17541941     DOI: 10.1002/jcb.21379

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  16 in total

Review 1.  Current mouse and cell models in prostate cancer research.

Authors:  Xinyu Wu; Shiaoching Gong; Pradip Roy-Burman; Peng Lee; Zoran Culig
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

2.  Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.

Authors:  Kouji Izumi; Lei Li; Chawnshang Chang
Journal:  Clin Investig (Lond)       Date:  2014-10-01

3.  Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells.

Authors:  Gema Martin-Manso; Susana Galli; Lisa A Ridnour; Maria Tsokos; David A Wink; David D Roberts
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

4.  Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy.

Authors:  Kiran Gollapudi; Colette Galet; Tristan Grogan; Hong Zhang; Jonathan W Said; Jiaoti Huang; David Elashoff; Stephen J Freedland; Matthew Rettig; William J Aronson
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

5.  Cancer biomarker discovery: the entropic hallmark.

Authors:  Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

6.  Characterization of tumor-associated macrophages in prostate cancer transgenic mouse models.

Authors:  Amber E de Groot; Kayla V Myers; Timothy E G Krueger; Ashley L Kiemen; Natalia H Nagy; Alexandria Brame; Vicente E Torres; Zhongyuan Zhang; Levent Trabzonlu; W Nathaniel Brennen; Denis Wirtz; Angelo M De Marzo; Sarah R Amend; Kenneth J Pienta
Journal:  Prostate       Date:  2021-05-05       Impact factor: 4.012

7.  Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer.

Authors:  K L Mahon; H-M Lin; L Castillo; B Y Lee; M Lee-Ng; M D Chatfield; K Chiam; S N Breit; D A Brown; M P Molloy; G M Marx; N Pavlakis; M J Boyer; M R Stockler; R J Daly; S M Henshall; L G Horvath
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

8.  Effect of Negative Pressure Therapy on the Inflammatory Response of the Intestinal Microenvironment in a Porcine Septic Model.

Authors:  Kenneth C Norbury; Mary Pat Moyer
Journal:  Mediators Inflamm       Date:  2015-07-30       Impact factor: 4.711

9.  M2-polarized macrophages promote metastatic behavior of Lewis lung carcinoma cells by inducing vascular endothelial growth factor-C expression.

Authors:  Bicheng Zhang; Yafei Zhang; Guoqing Yao; Juan Gao; Bo Yang; Yong Zhao; Zhiguo Rao; Jianfei Gao
Journal:  Clinics (Sao Paulo)       Date:  2012-08       Impact factor: 2.365

10.  Inhibition of CCL2 signaling in combination with docetaxel treatment has profound inhibitory effects on prostate cancer growth in bone.

Authors:  Peter S Kirk; Theodore Koreckij; Holly M Nguyen; Lisha G Brown; Linda A Snyder; Robert L Vessella; Eva Corey
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.